This morning, Array Biopharma will outline its plans to investors to get its first wholly-owned drug, a treatment for the blood cancer multiple myeloma, approved by the Food and Drug Administration.
Every company has a journey and Sumeet Shrivastava shares with Editor Nick Wakeman the path Array Information Technologies followed from when he joined as CEO in 2008 to its recent sale to CGI Federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results